US Patent Issued to GAIA on Aug. 25 for "Enhancement and stabilization GLP and GPI drug effects on the limbic system by providing digital cognitive behavioral therapy" (German Inventors)

ALEXANDRIA, Va., Aug. 25 -- United States Patent no. 12,718,921, issued on Aug. 25, was assigned to GAIA AG (Hamburg, Germany).

"Enhancement and stabilization GLP and GPI drug effects on the limbic system by providing digital cognitive behavioral therapy" was invented by Mario Weiss (Hamburg, Germany), Tristan Zindler (Hamburg, Germany) and Bernhard Wellhofer (Hamburg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Psychotherapy techniques can lead to significant changes in the limbic system of a patient, thereby enhancing emotional regulation, reducing impacts of stress, facilitating healthier memory processing, and supporting behavioral changes. These transformations are essential to the effectiven...